Clinical article
Reliability of Oculomotor Biomarkers
Discover the reliability of oculomotor biomarkers and how consistent eye movement metrics support early detection of neurological disorders
24 June 2025
Read more
Clinical article
Exploring Anti-Saccades and Frontal Lobe Function
Learn more about how neuroClues® eye movement biomarkers could support early detection of cognitive impairments.
6 May 2025
Clinical article
Neural Pathways of Voluntary and Reflexive Saccades
Learn more about the differences between voluntary and reflexive saccades, the structures involved in those movements, and how they can provide interesting clues about brain health.
15 April 2025
Clinical article
Oculomotor Biomarkers Recorded on 50 Patients with neuroClues®, now CE-Marked!
Learn more about neuroClues®’ role in the ICEBERG cohort with 50 patients recorded, and how eye movement analysis is advancing cognitive impairment detection.
4 March 2025
Press release
neuroClues verkrijgt CE-certificering voor zijn eye-tracking technologie die de neurologische zorg moet verbeteren
Volgende stap: neuroClues op de Europese markt lanceren en de “stethoscoop van de hersenen” worden Samengevat neuroClues behaalt MDR-certificering (Medical Device Regulation) en mag
7 January 2025
Press release
neuroClues secures CE certification for its eye-tracking technology set to enhance neurologic care
In summary neuroClues achieves Medical Device Regulation (MDR) certification and is now allowed to issue the CE-mark on its Class IIa medical device designed
7 January 2025
Clinical article
Reference Oculomotor Ranges in Eye Tracking with NeuroClues
Explore how neuroClues calculates the reference oculomotor ranges in eye tracking, with exclusive insights into the technical details.
17 December 2024
Clinical article
Eye Movements: A Key to Supporting Pharmaceutical Research
Explore recent studies on how eye movements can support pharmaceutical research in diagnosing, monitoring, and developing new neurological treatments.
8 November 2024
Clinical article
Clinical highlights: Multiple Sclerosis (MS)
The newsletter of this month will emphasize the latest research about Multiple Sclerosis
29 August 2024
Clinical article
Clinical highlights: Alzheimer’s Disease (AD)
The newsletter of this month will emphasize the latest research about Alzheimer’s Disease
19 July 2024
